FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100045527> ?p ?o ?g. }

• W2100045527 endingPage "144" @default.
• W2100045527 startingPage "140" @default.
• W2100045527 abstract "Rate of thalidomide-related VTE and risk factors in Japanese myeloma patients are not clear and effects of thromboprophylaxis remain controvertial.We retrospectively analyzed a cohort data of registered Japanese myeloma patients treated with thalidomide-based regimens between 2009 and 2010. Primary endpoint was rate of symptomatic VTE. Secondary endpoints were associations between VTE and clinical factors including age, gender, disease characteristics and duration, history of VTE, immobilization, comorbidities, treatment regimens, and laboratory parameters of Hb, leukocyte, platelet and FDP or D-dimer level, and effects of thromboprophylaxis with aspirin or warfarin. Statistical analysis was performed by Fischer's exact test and Cochran-Mantel-Haenszel test to control for confounders, and t test for dichotomous and continuous variables, respectively.1035 refractory or relapsed myeloma patients were followed up for a median of 112days(range 2-311days), and 14 (1.4%) developed VTE with a median treatment of 31days (range 9-134days) with thalidomide. Treatments with or without other agents lead to similar rates of VTE, 1.7% and 1.1%, respectively (p=0.43) and no specific clinical factors influenced development of VTE. Thromboprophylaxis with aspirin or warfarin did not reduce risk of VTE; VTE with or without aspirin: 1.4% and 1.3% (p=1.00), and warfarin: 2.4% and 1.3% (0.31), respectively.Rate of VTE is low in Japanese myeloma patients treated with thalidomide. Risk factors and effects of thromboprophylaxis with aspirin or warfarin are not apparent, however, controlled randomized studies of larger scale are needed for statistically valid conclusion." @default.
• W2100045527 created "2016-06-24" @default.
• W2100045527 creator A5047200285 @default.
• W2100045527 creator A5051502371 @default.
• W2100045527 creator A5058529290 @default.
• W2100045527 creator A5066086564 @default.
• W2100045527 creator A5078524474 @default.
• W2100045527 creator A5084450053 @default.
• W2100045527 creator A5091358519 @default.
• W2100045527 date "2013-02-01" @default.
• W2100045527 modified "2023-10-12" @default.
• W2100045527 title "A retrospective cohort study of venous thromboembolism(VTE) in 1035 Japanese myeloma patients treated with thalidomide; lower incidence without statistically significant association between specific risk factors and development of VTE and effects of thromboprophylaxis with aspirin and warfarin" @default.
• W2100045527 cites W1544335863 @default.
• W2100045527 cites W1587685635 @default.
• W2100045527 cites W1596204321 @default.
• W2100045527 cites W1987068734 @default.
• W2100045527 cites W1995391277 @default.
• W2100045527 cites W1996600303 @default.
• W2100045527 cites W2023978477 @default.
• W2100045527 cites W2027190006 @default.
• W2100045527 cites W2028179512 @default.
• W2100045527 cites W2035056966 @default.
• W2100045527 cites W2043133560 @default.
• W2100045527 cites W2049268214 @default.
• W2100045527 cites W2050624503 @default.
• W2100045527 cites W2063659217 @default.
• W2100045527 cites W2088348963 @default.
• W2100045527 cites W2089893027 @default.
• W2100045527 cites W2097331346 @default.
• W2100045527 cites W2107353588 @default.
• W2100045527 cites W2109113725 @default.
• W2100045527 cites W2113020324 @default.
• W2100045527 cites W2115099946 @default.
• W2100045527 cites W2136453813 @default.
• W2100045527 cites W2136549883 @default.
• W2100045527 cites W2147143600 @default.
• W2100045527 cites W2415511892 @default.
• W2100045527 doi "https://doi.org/10.1016/j.thromres.2012.11.014" @default.
• W2100045527 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23232090" @default.
• W2100045527 hasPublicationYear "2013" @default.
• W2100045527 type Work @default.
• W2100045527 sameAs 2100045527 @default.
• W2100045527 citedByCount "14" @default.
• W2100045527 countsByYear W21000455272014 @default.
• W2100045527 countsByYear W21000455272015 @default.
• W2100045527 countsByYear W21000455272016 @default.
• W2100045527 countsByYear W21000455272017 @default.
• W2100045527 countsByYear W21000455272019 @default.
• W2100045527 countsByYear W21000455272021 @default.
• W2100045527 countsByYear W21000455272022 @default.
• W2100045527 countsByYear W21000455272023 @default.
• W2100045527 crossrefType "journal-article" @default.
• W2100045527 hasAuthorship W2100045527A5047200285 @default.
• W2100045527 hasAuthorship W2100045527A5051502371 @default.
• W2100045527 hasAuthorship W2100045527A5058529290 @default.
• W2100045527 hasAuthorship W2100045527A5066086564 @default.
• W2100045527 hasAuthorship W2100045527A5078524474 @default.
• W2100045527 hasAuthorship W2100045527A5084450053 @default.
• W2100045527 hasAuthorship W2100045527A5091358519 @default.
• W2100045527 hasConcept C120665830 @default.
• W2100045527 hasConcept C121332964 @default.
• W2100045527 hasConcept C126322002 @default.
• W2100045527 hasConcept C141071460 @default.
• W2100045527 hasConcept C167135981 @default.
• W2100045527 hasConcept C2776301958 @default.
• W2100045527 hasConcept C2776364478 @default.
• W2100045527 hasConcept C2777628954 @default.
• W2100045527 hasConcept C2779161974 @default.
• W2100045527 hasConcept C2779609412 @default.
• W2100045527 hasConcept C61511704 @default.
• W2100045527 hasConcept C71924100 @default.
• W2100045527 hasConcept C72563966 @default.
• W2100045527 hasConcept C90924648 @default.
• W2100045527 hasConceptScore W2100045527C120665830 @default.
• W2100045527 hasConceptScore W2100045527C121332964 @default.
• W2100045527 hasConceptScore W2100045527C126322002 @default.
• W2100045527 hasConceptScore W2100045527C141071460 @default.
• W2100045527 hasConceptScore W2100045527C167135981 @default.
• W2100045527 hasConceptScore W2100045527C2776301958 @default.
• W2100045527 hasConceptScore W2100045527C2776364478 @default.
• W2100045527 hasConceptScore W2100045527C2777628954 @default.
• W2100045527 hasConceptScore W2100045527C2779161974 @default.
• W2100045527 hasConceptScore W2100045527C2779609412 @default.
• W2100045527 hasConceptScore W2100045527C61511704 @default.
• W2100045527 hasConceptScore W2100045527C71924100 @default.
• W2100045527 hasConceptScore W2100045527C72563966 @default.
• W2100045527 hasConceptScore W2100045527C90924648 @default.
• W2100045527 hasIssue "2" @default.
• W2100045527 hasLocation W21000455271 @default.
• W2100045527 hasLocation W21000455272 @default.
• W2100045527 hasOpenAccess W2100045527 @default.
• W2100045527 hasPrimaryLocation W21000455271 @default.
• W2100045527 hasRelatedWork W1976805847 @default.
• W2100045527 hasRelatedWork W2014876946 @default.
• W2100045527 hasRelatedWork W2037421482 @default.
• W2100045527 hasRelatedWork W2166050490 @default.
• W2100045527 hasRelatedWork W2346101032 @default.
• W2100045527 hasRelatedWork W2353978678 @default.

• next